Opportunity Information: Apply for RFI 72011519RFA00001

The USAID/Kyrgyz Republic Tuberculosis (TB) Control Program notice (RFI 72011519RFA00001) is a Request for Information rather than a full funding solicitation. It is being issued by USAID (listed under the Kazakhstan USAID-Almaty office) as an early step to shape and refine an upcoming tuberculosis program in the Kyrgyz Republic. The purpose is to gather practical input from interested organizations and stakeholders so USAID can improve the eventual Program Description (PD) and overall program design before moving forward with a formal competitive funding opportunity.

This opportunity sits in the health sector and anticipates a future award mechanism structured as a cooperative agreement, which typically means the recipient would implement activities with substantial USAID involvement during execution (for example, collaboration on technical direction, monitoring, and adaptive management). The listing shows the opportunity category as discretionary and indicates eligibility as unrestricted, suggesting that, at the RFI stage, USAID is open to receiving feedback from a broad range of respondents rather than limiting participation to a narrow applicant class. The notice includes a CFDA/Assistance Listing reference of 98.001, which is commonly associated with USAID foreign assistance programming.

What USAID is requesting is concise and targeted: a short response of about two pages that focuses on (1) which parts of the draft or conceptual Program Description are unclear, incomplete, or would benefit from additional detail, and (2) specific recommendations to improve the PD. In practice, that kind of input might include pointing out ambiguities in objectives, proposed results framework, geographic or population focus, implementation expectations, partner coordination assumptions, monitoring and evaluation requirements, and any gaps that could create confusion or implementation risk later. The intent is not to submit a full technical proposal or budget at this stage, but to provide constructive feedback that will make the eventual solicitation clearer, more implementable, and better aligned with on-the-ground realities of TB control programming in Kyrgyzstan.

The notice lists an original closing date of December 14, 2018. It also shows an award ceiling of 0 and does not specify the number of expected awards, which is consistent with an RFI because USAID is not yet committing funds or making awards through this announcement. The creation date is March 1, 2018, reinforcing that this was an early market-research and program-design step meant to inform a later, formal funding competition.

  • The Kazakhstan USAID-Almaty in the health sector is offering a public funding opportunity titled "USAID/Kyrgyz Republic Tuberculosis (TB) Control Program" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
  • This funding opportunity was created on 2018-03-01.
  • Applicants must submit their applications by 2018-12-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: Unrestricted.
Apply for RFI 72011519RFA00001

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

FAQs: USAID/Kyrgyz Republic Tuberculosis (TB) Control Program (RFI 72011519RFA00001)

1) What is this notice (72011519RFA00001) actually for?

This notice is a Request for Information (RFI) for the USAID/Kyrgyz Republic Tuberculosis (TB) Control Program. It is not a full funding solicitation. USAID is using it as an early step to collect practical input that will help shape and refine a future TB program in the Kyrgyz Republic.

2) Is this a grant application or a request for feedback?

It is a request for feedback. The purpose is to gather input from organizations and stakeholders so USAID can improve the eventual Program Description (PD) and overall program design before launching a formal competitive funding opportunity.

3) Does responding to this RFI mean USAID will make an award now?

No. The notice shows an award ceiling of 0 and does not specify the number of expected awards, which aligns with an RFI. This announcement is not a commitment to fund or to make awards.

4) What sector and country does this opportunity relate to?

The notice sits in the health sector and focuses on tuberculosis (TB) control programming in the Kyrgyz Republic.

5) Who is issuing the RFI?

The RFI is issued by USAID and is listed under the Kazakhstan USAID-Almaty office in the notice details.

6) What award type is anticipated for the future opportunity?

The notice anticipates that the future award mechanism will be a cooperative agreement. A cooperative agreement typically involves substantial USAID involvement during implementation, such as collaboration on technical direction, monitoring, and adaptive management.

7) What is USAID asking respondents to submit?

USAID is requesting a concise, targeted response of about two pages. The response should focus on (1) what parts of the draft or conceptual Program Description are unclear, incomplete, or need more detail, and (2) specific recommendations to improve the Program Description.

8) What should the feedback be about (what topics are relevant)?

Based on the notice, relevant input can include highlighting ambiguities or gaps in items such as objectives, a proposed results framework, geographic or population focus, implementation expectations, partner coordination assumptions, monitoring and evaluation requirements, and other issues that could create confusion or implementation risk later.

9) Is USAID asking for a full technical proposal at this stage?

No. The intent is not to submit a full technical proposal at the RFI stage. The notice emphasizes constructive feedback to make the eventual solicitation clearer and more implementable.

10) Is USAID asking for a budget with the RFI response?

No. The notice indicates this stage is meant for feedback on the Program Description and program design, not for submitting a budget.

11) Who is eligible to respond?

The notice lists eligibility as unrestricted. At the RFI stage, this suggests USAID is open to receiving feedback from a broad range of respondents rather than limiting participation to a narrow applicant class.

12) What does the opportunity category "discretionary" mean here?

The listing shows the opportunity category as discretionary. In the context provided, the key takeaway is that this is an informational step intended to inform a later competitive funding action, not a current award action.

13) What is the CFDA/Assistance Listing reference for this notice?

The notice includes a CFDA/Assistance Listing reference of 98.001, which is commonly associated with USAID foreign assistance programming.

14) What is the deadline listed for the RFI?

The notice lists an original closing date of December 14, 2018.

15) When was the notice created?

The creation date shown is March 1, 2018, indicating it was positioned as early market research and program design input ahead of a later, formal competition.

16) Why is USAID doing an RFI before a formal solicitation?

The purpose is to gather practical input from interested organizations and stakeholders so USAID can refine the Program Description and overall design. The goal is to make the eventual solicitation clearer, more implementable, and better aligned with on-the-ground realities of TB control programming in Kyrgyzstan.

17) Does the RFI provide details on the number of expected awards?

No. The notice does not specify the number of expected awards, which is consistent with an RFI because it is not making an award commitment.

18) What should respondents try to achieve with their comments?

Respondents should aim to provide constructive, specific recommendations that help USAID clarify unclear parts of the draft or conceptual Program Description and reduce later confusion or implementation risk once a formal competitive funding opportunity is issued.

Browse more opportunities from the same agency: Kazakhstan USAID-Almaty

Browse more opportunities from the same category: Health

Next opportunity: EDA Denver FY 2016–FY 2019 Planning Program and Local Technical Assistance Program

Previous opportunity: Pilot and Feasibility Studies of HIV and Animal Models for HIV Infection within the Mission of NIDDK (R21 Clinical Trial Optional)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFI 72011519RFA00001

 

Applicants also applied for:

Applicants who have applied for this opportunity (RFI 72011519RFA00001) also looked into and applied for these:

Funding Opportunity
Center without Walls for PET Ligand Development for Alzheimer's disease related dementias (ADRDs) (U19 Clinical Trial Optional) Apply for RFA NS 18 025

Funding Number: RFA NS 18 025
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Interdisciplinary Research Teams to Investigate Reciprocal Basic Behavioral and Social Linkages Between Sleep and Stress (R24 Clinical Trial Optional) Apply for PAR 18 694

Funding Number: PAR 18 694
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required) Apply for PAR 18 696

Funding Number: PAR 18 696
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Basic and Translational Oral Health Research Related to HIV/AIDS (R01 Clinical Trial Not Allowed) Apply for PA 18 699

Funding Number: PA 18 699
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Advanced Laboratories for Accelerating the Reach and Impact of Treatments for Youth and Adults with Mental Illness (ALACRITY) Research Centers (P50 Clinical Trial Optional) Apply for PAR 18 701

Funding Number: PAR 18 701
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,000,000
Natural Product, Multi-Site, Clinical Trial, Data Coordinating Center (Collaborative U24 - Clinical Trial Required) Apply for PAR 18 697

Funding Number: PAR 18 697
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Stimulating T4 Implementation Research to Optimize Integration of Proven-effective Interventions for Heart, Lung, and Blood Diseases and Sleep Disorders into Practice (STIMULATE) (R01 Clinical Trial Not Allowed) Apply for RFA HL 19 014

Funding Number: RFA HL 19 014
Agency: National Institutes of Health
Category: Health
Funding Amount: $485,000
Basic and Translational Oral Health Research Related to HIV/AIDS (R21 Clinical Trial Not Allowed) Apply for PA 18 695

Funding Number: PA 18 695
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (Clinical Trials Not Allowed) Apply for PA 18 700

Funding Number: PA 18 700
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NEI Translational Research Program (TRP) on Therapy for Visual Disorders (R24 Clinical Trial Optional) Apply for PAR 18 707

Funding Number: PAR 18 707
Agency: National Institutes of Health
Category: Health
Funding Amount: $1,500,000
Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01 - Clinical Trial Not Allowed) Apply for PAR 18 706

Funding Number: PAR 18 706
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Autoimmunity Centers of Excellence, Basic Research Program (U19 Clinical Trial Not Allowed) Apply for RFA AI 18 002

Funding Number: RFA AI 18 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Autoimmunity Centers of Excellence, Clinical Research Program (UM1 Clinical Trial Required) Apply for RFA AI 18 003

Funding Number: RFA AI 18 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIDCD Research Dissertation Fellowship for Au.D. Audiologists (F32) (Clinical Trials Not Allowed) Apply for PAR 18 700

Funding Number: PAR 18 700
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed) Apply for PAR 18 714

Funding Number: PAR 18 714
Agency: National Institutes of Health
Category: Health
Funding Amount: $300,000
Technologies for Healthy Independent Living for Heart, Lung, Blood and Sleep Disorders (R43 - Clinical Trial Not Allowed) Apply for RFA HL 19 016

Funding Number: RFA HL 19 016
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Transition Award for NINDS Intramural Clinician-Scientists (K22) - Clinical Trial Required Apply for PAR 18 710

Funding Number: PAR 18 710
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed) Apply for PAR 18 711

Funding Number: PAR 18 711
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R41/R42)-Clinical Trial Not Allowed Apply for PA 18 709

Funding Number: PA 18 709
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Genomic Centers for Infectious Diseases (U19 Clinical Trial Not Allowed) Apply for RFA AI 18 004

Funding Number: RFA AI 18 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFI 72011519RFA00001", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: